**Page:** 10

## Alphabet Inc. CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions; unaudited)

|                                                                        | Nine Months Ended September 30,   | Nine Months Ended September 30,   |
|------------------------------------------------------------------------|-----------------------------------|-----------------------------------|
|                                                                        | 2023                              | 2024                              |
| Operating activities                                                   |                                   |                                   |
| Net income                                                             | $ 53,108                          | $ 73,582                          |
| Adjustments:                                                           |                                   |                                   |
| Depreciation of property and equipment                                 | 8,630                             | 11,106                            |
| Stock-based compensation expense                                       | 16,801                            | 16,975                            |
| Deferred income taxes                                                  | (6,093)                           | (3,809)                           |
| Loss (gain) on debt and equity securities, net                         | 1,294                             | (2,738)                           |
| Other                                                                  | 2,665                             | 2,592                             |
| Changes in assets and liabilities, net of effects of acquisitions:     |                                   |                                   |
| Accounts receivable, net                                               | (1,315)                           | (1,321)                           |
| Income taxes, net                                                      | 10,392                            | (2,797)                           |
| Other assets                                                           | (2,883)                           | (2,334)                           |
| Accounts payable                                                       | 237                               | (42)                              |
| Accrued expenses and other liabilities                                 | (380)                             | (6,366)                           |
| Accrued revenue share                                                  | (315)                             | 478                               |
| Deferred revenue                                                       | 690                               | 860                               |
| Net cash provided by operating activities                              | 82,831                            | 86,186                            |
| Investing activities                                                   |                                   |                                   |
| Purchases of property and equipment                                    | (21,232)                          | (38,259)                          |
| Purchases of marketable securities                                     | (49,422)                          | (65,034)                          |
| Maturities and sales of marketable securities                          | 52,642                            | 81,779                            |
| Purchases of non-marketable securities                                 | (2,176)                           | (3,234)                           |
| Maturities and sales of non-marketable securities                      | 743                               | 732                               |
| Acquisitions, net of cash acquired, and purchases of intangible assets | (466)                             | (2,840)                           |
| Other investing activities                                             | (985)                             | (2,500)                           |
| Net cash used in investing activities                                  | (20,896)                          | (29,356)                          |
| Financing activities                                                   |                                   |                                   |
| Net payments related to stock-based award activities                   | (7,157)                           | (9,141)                           |
| Repurchases of stock                                                   | (45,313)                          | (46,671)                          |
| Dividend payments                                                      | 0                                 | (4,921)                           |
| Proceeds from issuance of debt, net of costs                           | 9,298                             | 8,694                             |
| Repayments of debt                                                     | (9,621)                           | (8,951)                           |
| Proceeds from sale of interest in consolidated entities, net           | 8                                 | 293                               |
| Net cash used in financing activities                                  | (52,785)                          | (60,697)                          |
| Effect of exchange rate changes on cash and cash equivalents           | (327)                             | (222)                             |
| Net increase (decrease) in cash and cash equivalents                   | 8,823                             | (4,089)                           |
| Cash and cash equivalents at beginning of period                       | 21,879                            | 24,048                            |
| Cash and cash equivalents at end of period                             | $ 30,702                          | $ 19,959                          |